Takeda, K.; Ohta, S.; Nagao, M.; Kobayashi, E.; Tago, K.; Funakoshi-Tago, M.
FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5. Int. J. Mol. Sci. 2024, 25, 3693.
https://doi.org/10.3390/ijms25073693
AMA Style
Takeda K, Ohta S, Nagao M, Kobayashi E, Tago K, Funakoshi-Tago M.
FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5. International Journal of Molecular Sciences. 2024; 25(7):3693.
https://doi.org/10.3390/ijms25073693
Chicago/Turabian Style
Takeda, Kengo, Satoshi Ohta, Miu Nagao, Erika Kobayashi, Kenji Tago, and Megumi Funakoshi-Tago.
2024. "FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5" International Journal of Molecular Sciences 25, no. 7: 3693.
https://doi.org/10.3390/ijms25073693
APA Style
Takeda, K., Ohta, S., Nagao, M., Kobayashi, E., Tago, K., & Funakoshi-Tago, M.
(2024). FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5. International Journal of Molecular Sciences, 25(7), 3693.
https://doi.org/10.3390/ijms25073693
